Alzheimer's disease (AD) is a chronic neurodegenerative disorder associated with
dementia. To overcome the limitations of diagnosis and treatment nanotechnology research …

Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and affects more
than 10% of the population aged over 65 worldwide. Despite considerable global efforts, AD …

A label-free biosensor is developed for the determination of plasma-based Aβ 1–42
biomarker in Alzheimer's disease (AD). The platform is based on highly conductive dual …

Alzheimer's disease (AD) is an incurable and highly debilitating condition characterized by
the progressive degeneration and/or death of nerve cells, which leads to manifestation of …

The increase in the demand and popularity of smart biosensors has brought a novel and
innovative concept to develop a diverse range of semen mutual biomarker (ie, prostate …

New highly sensitive direct methods for the early detection of peptides involved in
Alzheimer's disease (AD) are required in order to prolong effective and healthy memory and …

A reduced graphene oxide-based enzyme-modified field-effect transistor (RGO-EnFET) was
fabricated to study the enzymatic kinetics between acetylcholinesterase (AChE) and …

Alzheimer's disease is a debilitating and largely untreatable condition with subtle onset and
slow progression over an extensive period of time, which culminate in increasing levels of …

Proteomics is an essential technology in medicine and biotechnology. Protein profiling and
its application in disease diagnosis have attracted a lot of attention from scientists. Highly …

Quantifying physical differences of protein aggregates implicated in Alzheimer's disease
(AD), in blood, could provide crucial information on disease stages. Here, red blood cells …